@DocforMS

Director of the OMRF Multiple Sclerosis Center of Excellence, where MS is approached with optimal clinical care and scientific innovation. Opinions are my own.

 USA
Joined March 2011
  • Tweets417
  • Following159
  • Followers1.1K
20Media
Celebrating #WorldMSday 2026 by giving our #MS warriors a creative space. Working -with soul and science- for a better future @OMRF
3
3
166
Innovative ways to assess disease status and progression in #MS is an unmet need. Proud of our team's work using eye movement analysis as a way to assess cognition and correlate with functional and anatomical metrics @OMRF journals.sagepub.com/doi/10.…

Eye movement analysis during working memory tasks correlates with cognitive, clinical, and anatom...

Background Cognitive dysfunction involving working memory is common in multiple sclerosis (MS) but is often under-detected in clinical assessments. Noninvasive ...

journals.sagepub.com
2
4
1
16
714
Dr. Gabriel Pardo retweeted
Joe Sabatino@jsabatino37
Jan 13
EBV is required for the development of multiple sclerosis, but it’s not known how a common virus leads to disease. 3 exciting new papers in @CellCellPress provide major insights into how this may occur:
1
11
1
23
3,115
Six-year safety and efficacy outcomes with first-line ofatumumab in re... sciencedirect.com/science/ar… Exploring longterm effects of early initiation of highly effective treatment as first line in MS; positive data!
1
3
185
Repairing MS: The Quest to Rebuild Myelin New MS Living Well Podcast🎙️Guests: Veronique Miron PhD🇨🇦 @UofT & Rob Glanzman MD 🇺🇸 bit.ly/47BfjJ8 🍏apple.co/3JUhTQz @MSCanOfficial @DrJim4MS @MStranslate @DocforMS @DrJNicholas Sponsor: @TGTherapeutics
4
4
21
1,254
#ECTRIMS2025 coming up in Sept. 24-26 in Barcelona. Off to Toronto, Canada in 2026! ⛸️ Advances in #MS🌲#ECTRIMS2026! 🇨🇦 @AlexMuccilli @MSDoc_Freedman @DocforMS @DrJNicholas @Brandon_Beaber @C_OrejaGuevara @KlausSchmierer @J_SastreGarriga @bart_professor @anneke_vdw @ECTRIMS
1
6
25
1,642
🚀Boosting Brain Health: Blueprint for MS New MS Living Well Podcast 🎧🚶‍♀️🥗😴🧘‍♀️ bit.ly/3FyR2b0🍏apple.co/4jHbiow @KlausSchmierer @DocforMS @anneke_vdw @C_OrejaGuevara @ahmedzobeidat @bart_professor Sponsor: @TGTherapeutics
3
14
801
Want to learn more about visual involvement in MS? Watch this: Bringing MS Vision Problems Into Focus - Can Do MS. cando-ms.org/resource/bringi…

Bringing MS Vision Problems Into Focus - Can Do MS

cando-ms.org
1
6
256
Advocacy in action! Fearless Lea Campbell obtained -again- a Governor’s proclamation making March the #NMOSD month in Oklahoma. #MOGAD #raredisease @guthyjacksonfdn @TheSumairaFDN @OMRF
1
2
10
745
How can functional, anatomic, and biologic tools optimize treatment and risk mitigation for people with progressive #multiplesclerosis? Read Dr. Pardo's (@DocforMS) review article in our February issue. practicalneurology.com/artic… @OMRF @mscare @mssociety @AANmember @ACTRIMS @ACPIMPhysicians #MS
1
3
699
Proud to share ongoing work on novel approaches to quantifying #MS impact. @ViewMind_ Eye movement deficits in Multiple Sclerosis: characterizing executive ... sciencedirect.com/science/ar…
1
173
Happy to share this collaborative work looking at long term results of a high efficacy DMT in early #MS #ocrelizumab ⁦@OMRF⁩ ⁦⁦@AaronBosterMD⁩ ⁦@drbarrysinger⁩ ⁦@Brandon_Beaber⁩ ⁦@MSViewsandNews⁩ neurology.org/doi/10.1212/WN…

Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS | Neurology

Background and ObjectivesPatients with multiple sclerosis (MS) may demonstrate better disease control when treatment is initiated on high-efficacy disease-modifying therapies (DMTs) from onset. This...

neurology.org
3
11
2
48
3,627
Dr. Gabriel Pardo retweeted
Saisree Ravi, MD@SaisreeRaviMD
1 Feb 2025
Thought-provoking discussion about gaps in MS treatments and the role of microglia and CNS targeting therapies by @DocforMS at #TNSW2025 @Texas_Neuros
2
4
477
So happy to share the day, knowledge, and experiences with 400+ patients and caregivers at Dr. Khatri’s Living Well with #MS and Other Autoimmune Neurological Disorders in Milwaukee. #NMOSD #MOGAD @OMRF
20
609
Patient education day #NMOSD #MOGAD with the @guthyjacksonfdn in OKC. Committed to improving care and science of rare diseases
19
794
Have you ever wondered about the magnitude of new/unused disease modifying therapies for multiple sclerosis that may be out there? Retail costs for these specialty medicines are near $100K per year! This is a before and after photo from 2020. Imagine for a minute what we have collected up to present day. Enthusiasm for fixing the problem is low especially when compensation has already occurred along the distribution chain. @davidbalat @patientsrising @ectrims @actrims @mssociety @docforms @DrugChannels @elonmusk
1
11
3
16
3,742
Highlighting our latest work on elucidating mechanisms of disease. Obesity intensifies sex-specific interferon signaling to selectively w... @omrf @drbarrysinger @C_OrejaGuevara @Brandon_Beaber @AaronBosterMD @NerdyNeuroMD sciencedirect.com/science/ar…
4
2
12
2,063
MS & The Spinal Cord; New MS Living Well podcast🎙️ Guests: Drs. Cree & De Luca. 80% of people with #MS have spinal cord lesions on MRI. bit.ly/4dsbd68🍎apple.co/3MfHFN3 @KlausSchmierer @C_OrejaGuevara @Brandon_Beaber @themsguide @MustStopMS @DocforMS @jsabatino37
2
7
22
2,026
⏰ Counting down the days until I present my research at #ECTRIMS2024. Looking forward to engaging discussions and learning from fellow researchers and practitioners. #MS #msresearch app.sosha.ai/s/1BG5gydj

Visit the ECTRIMS 2024 Website

app.sosha.ai
11
323
Dr. Gabriel Pardo retweeted
OMRF@OMRF
4 Jun 2024
Dr. Yang Mao-Draayer will serve as director of clinical and experimental therapeutics in OMRF’s Arthritis and Clinical Immunology Research Program. She also will treat MS patients and direct OMRF’s neuroimmunology lab. Read more: omrf.org/2024/05/30/omrf-wel…
1
9
489
Load more